Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
28.26
+0.78 (2.84%)
May 4, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biotechnology (Startups)
1.20M686.00K883.00K912.00K960.00K
Biotechnology (Startups) Growth
74.78%-22.31%-3.18%-5.00%-3.32%
Total
1.20M686.00K883.00K912.00K960.00K
Total Growth
74.78%-22.31%-3.18%-5.00%-3.32%
Source: S&P Global Market Intelligence.